Release Date: 03/10/14 08:30 Summary: Statement re Share Price Movement Price Sensitive: No Download Document 128.69KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%